PATRIZI, CLARISSA
 Distribuzione geografica
Continente #
NA - Nord America 661
EU - Europa 460
AS - Asia 143
OC - Oceania 22
AF - Africa 1
SA - Sud America 1
Totale 1.288
Nazione #
US - Stati Uniti d'America 649
IT - Italia 242
CN - Cina 61
GB - Regno Unito 55
SE - Svezia 48
DE - Germania 32
HK - Hong Kong 28
FR - Francia 23
SG - Singapore 23
AU - Australia 22
FI - Finlandia 11
CA - Canada 10
NL - Olanda 9
CH - Svizzera 8
KR - Corea 8
TR - Turchia 7
IN - India 6
BG - Bulgaria 5
IE - Irlanda 5
LT - Lituania 5
UA - Ucraina 4
ID - Indonesia 3
AT - Austria 2
BE - Belgio 2
CZ - Repubblica Ceca 2
GR - Grecia 2
JP - Giappone 2
MX - Messico 2
MY - Malesia 2
RO - Romania 2
BR - Brasile 1
ES - Italia 1
HR - Croazia 1
IR - Iran 1
PH - Filippine 1
RU - Federazione Russa 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 1.288
Città #
Fairfield 95
Chandler 67
Ashburn 60
Houston 42
Nyköping 41
Woodbridge 40
Southend 39
Seattle 35
Cambridge 34
Wilmington 32
Bologna 31
Hong Kong 27
Ann Arbor 20
Modena 19
Dearborn 18
Singapore 16
Beijing 12
Jacksonville 10
Bremen 9
Helsinki 9
New York 8
Princeton 8
Canberra 7
Redwood City 7
Adelaide 6
Izmir 6
Milan 6
Napoli 6
Padova 6
Amstelveen 5
Dallas 5
Sofia 5
Sydney 5
Avigliano Umbro 4
Des Moines 4
Eugene 4
Munich 4
Paris 4
Reggio Emilia 4
Rome 4
San Diego 4
Shanghai 4
Toronto 4
Trapani 4
Trento 4
Casagiove 3
Dublin 3
Empoli 3
Jakarta 3
Jongno-gu 3
London 3
Naples 3
Piacenza 3
Porretta Terme 3
San Francisco 3
San Jose 3
Siena 3
Zhengzhou 3
Assago 2
Aversa 2
Bergamo 2
Boardman 2
Brno 2
Buffalo 2
Cologno Monzese 2
Felino 2
Florence 2
Formigine 2
Gunzenhausen 2
Hefei 2
Jungnang-gu 2
Lappeenranta 2
Los Angeles 2
Lucca 2
Mexicali 2
Minerbio 2
Mississauga 2
Mytilene 2
Nanjing 2
New Delhi 2
Quistello 2
Roncoferraro 2
Simcoe 2
Soave 2
Somerville 2
Tokyo 2
Tongyeong 2
Torregrotta 2
Trim 2
Vienna 2
Wimbledon 2
Wolverhampton 2
Wuhan 2
Zurich 2
Balasore 1
Bangkok 1
Boston 1
Brescia 1
Brisbane 1
Brussels 1
Totale 901
Nome #
CRISPR/Cas9-mediated specific knock-down of dominant mutations in Rhodopsin gene 261
CRISPR/Cas9-Mediated In Situ Correction of LAMB3 Gene in Keratinocytes Derived from a Junctional Epidermolysis Bullosa Patient 253
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 217
Gene editing prospects for treating inherited retinal diseases 121
Allele-specific editing ameliorates dominant retinitis pigmentosa in a transgenic mouse model 118
CRISPR/Cas9 Allele-Specific Design To Inactivate A Dominant-Negative Mutation In COL6A1 Causing Ullrich Muscular Dystrophy 114
Specific Knock-down of P347S Dominant Mutation in Rhodopsin Gene by CRISPR/Cas9 System 67
Efficient CRISPR/Cas9-Mediated iIn Situ Correction of LAMB3 Gene in Keratinocytes Derived from Junctional Epidermolysis Bullosa Patient 57
Engineered Sleeping Beauty Transposon as Efficient System to Optimize Chimp Adenoviral Production 46
CRISPR/Cas9 allele-specifc design to inactivate a dominant-negative mutation in COL6A1 causing Ullrich muscular dystrophy. 34
Specific knock-down of C-terminal dominant mutation in Rhodopsin gene by CRISPR/Cas9 system 28
Totale 1.316
Categoria #
all - tutte 5.638
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.638


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020152 0 0 0 12 14 32 27 19 11 10 16 11
2020/2021232 15 8 7 27 23 13 8 18 14 55 34 10
2021/2022183 17 5 28 7 11 5 11 22 12 9 32 24
2022/2023328 23 37 37 30 64 28 10 23 33 8 20 15
2023/2024224 6 24 19 23 36 4 21 30 6 5 27 23
2024/202544 14 4 16 10 0 0 0 0 0 0 0 0
Totale 1.316